Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate whether the use of nicotine gum in the postoperative period influences surgical outcome in patients undergoing colorectal surgery.


Clinical Trial Description

The main hypothesis of this study is that use of nicotine gum after colorectal surgery will accelerate recovery of bowel function. Eligible patients include all patients undergoing segmental small bowel or large bowel resection with a planned primary anastomosis, planned removal of the nasogastric tube at the end of the surgery, and administration of clear liquids on post-operative day one. Patients who have an ileostomy or colostomy created will be excluded. Patients enrolled in the study will be randomized to one of three groups: nicotine gum, regular gum, or no gum. Patients randomized to nicotine gum or regular gum will chew the gum three times a day for 1 week. The main outcome measure is time to first bowel movement or flatus. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01662115
Study type Interventional
Source The Cleveland Clinic
Contact
Status Terminated
Phase Phase 4
Start date August 2012
Completion date June 2014

See also
  Status Clinical Trial Phase
Terminated NCT00443040 - Asimadoline for the Treatment of Post-Operative Ileus Phase 2
Recruiting NCT02673671 - G-Tech Feasibility Study for Early Detection of a Post-op Ileus
Completed NCT01869231 - Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus N/A
Recruiting NCT04009954 - Post-operative Ileus and Gut Microbiota